|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-12-2
|
|
pubmed:abstractText |
Triple receptor-negative breast cancers (TNBC) are higher grade and more likely to metastasize. Recurrences after 5 years are rare in TNBCs. Conversely, late recurrences are seen in estrogen receptor (ER)-positive (luminal) cancers. Disseminated tumor cells (DTCs) may be responsible for late recurrences. We compared rates of DTCs in basal and luminal subtypes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1534-4681
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3252-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20559739-Adult,
pubmed-meshheading:20559739-Aged,
pubmed-meshheading:20559739-Aged, 80 and over,
pubmed-meshheading:20559739-Breast Neoplasms,
pubmed-meshheading:20559739-Carcinoma, Basal Cell,
pubmed-meshheading:20559739-Female,
pubmed-meshheading:20559739-Humans,
pubmed-meshheading:20559739-Immunoenzyme Techniques,
pubmed-meshheading:20559739-Lymph Nodes,
pubmed-meshheading:20559739-Lymphatic Metastasis,
pubmed-meshheading:20559739-Middle Aged,
pubmed-meshheading:20559739-Prognosis,
pubmed-meshheading:20559739-Receptor, erbB-2,
pubmed-meshheading:20559739-Receptors, Estrogen,
pubmed-meshheading:20559739-Receptors, Progesterone
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients.
|
|
pubmed:affiliation |
Department of Surgical Oncology, Unit 444, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
